How to Buy Cencora Stock
Cencora Inc
Cencora is a medical distribution company located in Pennsylvania, United States, which is part of the Healthcare sector, and is traded under the ticker COR on the NYSE exchange.
Cencora stock last closed at $365.70, up 1.58% from the previous day, and has increased 48.21% in one year. It has underperformed other stocks in the Medical Distribution industry by 0.03 percentage points. Cencora stock is currently +53.84% from its 52-week low of $237.71, and -3.14% from its 52-week high of $377.54.
There are currently 194.53M shares of COR outstanding. The market cap of COR is $71.14B. In the past 24 hours, 895,000 COR shares were traded.
How to Buy Cencora Stock
Wondering how to invest in Cencora stock? Here's how.
- Decide where to buy Cencora stock: You need to decide on a stock brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you figure out where to buy Cencora stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
- Fund your investment account: Choose your payment method and add your details.
- Evaluate Cencora stock: The Cencora ticker symbol is COR. Is Cencora stock a good investment? Should you buy shares of COR? How do COR's underlying business fundamentals look? Do top analysts think Cencora is a good buy? Why has COR's stock price moved recently? (Hint: Our stock market analysis website can help you understand if COR is a good stock to buy).
- Make your COR buy order: Decide if you will purchase COR shares at the current market price or use a limit order to purchase COR stock at a specific price.
- Keep an eye on your COR investment: Create a watchlist to the latest updates on your new investment in Cencora stock.
Step 1: Decide where to buy Cencora stock
You need a brokerage account to access the NYSE market and buy COR shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've selected the right brokerage, the next step is to fill out some personal info so you are able to invest in COR today.
How to Create a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal info to create a new trading account.
- Submit your details by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you have created your account on the highest rated app to buy and sell stocks, you can securely and quickly fund your account:
Watch the video below if you need help depositing funds into your brokerage account.
Step 4: Evaluate Cencora stock
After you have figured out the best place to buy Cencora stock, it's absolutely critical to evaluate their stock before you buy, so you can comprehend the risk as well as the upside.
Cencora Metrics
COR Due Diligence Checks
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis.
You can view all of the due diligence checks on COR's stock page.
What is the fair value of COR stock?
You can use a variety of different financial metrics, analyses, models, and charts to gauge COR's true value.
Using relative valuations measures:
- COR may be overvalued based on its P/E ratio of 43.64x, relative to Medical Distribution industry P/E ratio of 32.69x
- COR may be undervalued based on its P/B ratio of 37.28x, relative to Medical Distribution industry P/B ratio of 280.23x
- COR may be overvalued based on its PEG ratio of 1.18x
You can access more valuation research on COR's stock here.
COR Financial Overview
Passed Financial Due Diligence Checks:
- There are more short-term assets than long-term liabilities on the COR balance sheet.
- COR's operating cash flow of $4.29B allows it to safely service it's debt of $7.92B.
- Total COR debt is lower than 5 years ago, relative to shareholder equity.
- COR earnings of $2.67B is not enough to cover its interest payments.
Failed Financial Due Diligence Checks:
- COR has a relatively high debt to equity ratio of 39.96.
- COR profit margin of X% has stayed the same in the past year.
- There are more short-term liabilities than short-term assets on the COR balance sheet.
Do Wall Street analysts think it's a good time to buy COR stock
Out of 11 Equities analysts who monitor COR, the consensus analyst rating on Cencora is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent COR Analyst Ratings
Michael Funk, a bottom 6% analyst from Bank of America maintains COR with a hold rating and lowers their COR price target from $380.00 to $360.00, on Jan 5, 2026.
Glen Santangelo, a top 29% analyst from Barclays initiates coverage on COR with a strong buy rating and announces their COR price target of $400.00, on Dec 9, 2025.
Charles Rhyee, a bottom 5% analyst from TD Cowen maintains COR with a strong buy rating and raises their COR price target from $350.00 to $400.00, on Nov 10, 2025.
Kevin Caliendo, a top 16% analyst from UBS maintains COR with a strong buy rating and raises their COR price target from $380.00 to $415.00, on Nov 7, 2025.
UBS's Kevin Caliendo raised their price target on Cencora (NYSE: COR) by 9.2% from $380 to $415 on 2025/11/07. The analyst maintained their Strong Buy rating on the stock.
Cencora reported its Q4 and FY 2025 earnings.
Caliendo argued that management's guidance for the company's U.S. Healthcare Solutions segment EBIT is doable, and perhaps conservative.
Earnings Report
Cencora reported:
For Q4 2025:
- EPS of $3.84, which beat the Zacks Consensus Estimate of $3.74 and Q4 2024 by 15%.
- Revenue of $83.73B, which beat the Zacks Consensus Estimate by 0.7% and was up 5.9% Y/Y.
For FY 2025:
- EPS of $16.00, up 16.3% Y/Y.
- Revenue of 321.33B, up 9.3% Y/Y.
For FY 2026, management guided:
- EPS of $17.45 to $17.75.
- 5% to 7% Y/Y revenue growth.
President & CEO Bob Mauch commented: “Cencora furthered key initiatives in fiscal 2025 to fortify our leading position in healthcare, most notably by enhancing our position in specialty through our acquisition of RCA, as well as the decision to strategically refocus our existing business portfolio.
“Our strategic drivers of prioritizing growth-oriented investments, accelerating digital transformation, cultivating a best-in-class team member culture, and enabling productivity position Cencora to drive value for our stakeholders.
“As we move into fiscal 2026, we are catalyzing growth and innovation, with our purpose at the core of all we do.
“Our increased long-term guidance reflects our confidence that Cencora's foundation in pharmaceutical distribution and leading capabilities, coupled with our focused execution, will continue driving growth well into the future.”
Dave Rodgers, a top 18% analyst from Baird maintains COR with a buy rating and raises their COR price target from $355.00 to $395.00, on Nov 6, 2025.
You can dig deeper into what analysts are projecting on the Cencora stock forecast page.
Metrics for Advanced COR Traders
How is COR performing as a company?
Last year, COR earnings were $1.63B. During the last four year, COR's earnings have gone up by 1.81% per year. This was slower than the Medical Distribution industry average of 21.02%.
Last year, COR revenue was $325.78B. During the past five year, COR's revenue has grown by 10.86% per year. This was faster than the Medical Distribution industry average of 10.13%.
You can analyze COR's earnings and revenue performance here.
Are COR executives and large shareholders buying or selling the stock?
In the past 12 months, insiders at COR have sold more shares than they have bought.
Robert P. Mauch, President CEO of COR, was the latest COR insider to buy. They bought $323,956.67 worth of COR shares on Jan 20, 2026.
Learn more about who owns COR stock here.
Can I get consistent income from COR stock?
Cencora pays a dividend of 0.46%, compared to the Medical Distribution industry's average dividend yield of 0.57%. If you owned $1,000 worth of COR stock, you would have received $4.65 in the past 12 months.
Cencora dividend payments have consistently grown over the past decade and have remained stable.
Get more info about Cencora dividend yield and history here.
COR Social Trading Data
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your COR buy order
There are two primary options:
- Market order: A market order is an order to buy or sell a stock at the best price on the market.
Market orders are generally fine. - Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a specific dollar amount limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want additional info about buying stocks on eToro, watch the how to video below:
Step 6: Keep an eye on your COR investment
Now that you own some COR stock, you'll want to keep up with your new company.
Start a watchlist to monitor your COR stock.
COR Feed
How to Buy Stock in Cencora
To summarize, here are the 6 steps to buy Cencora stock:
- Decide where to buy Cencora stock
- Sign up for your brokerage account
- Fund your investment account
- Evaluate Cencora stock
- Make your COR buy order
- Keep an eye on your COR investment
If you require a online brokerage, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest scoop on your investment in Cencora, add COR to your watchlist by clicking the button below.
More Stock Buying Guides You Might Find Useful
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.